X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11542) 11542
Publication (460) 460
Newspaper Article (68) 68
Book Review (39) 39
Book Chapter (35) 35
Book / eBook (11) 11
Conference Proceeding (11) 11
Magazine Article (5) 5
Reference (3) 3
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7735) 7735
iodine radioisotopes (5702) 5702
male (5525) 5525
animals (4951) 4951
female (4794) 4794
middle aged (2854) 2854
iodine radioisotopes - therapeutic use (2818) 2818
adult (2767) 2767
rats (2100) 2100
aged (2025) 2025
index medicus (1996) 1996
iodine radioisotopes - administration & dosage (1691) 1691
mice (1658) 1658
radionuclide imaging (1520) 1520
radiology, nuclear medicine & medical imaging (1372) 1372
tissue distribution (1138) 1138
oncology (1053) 1053
endocrinology & metabolism (1043) 1043
time factors (1025) 1025
thyroid neoplasms - radiotherapy (986) 986
radioisotopes (975) 975
cancer (937) 937
iodine radioisotopes - pharmacokinetics (917) 917
iodine (852) 852
adolescent (838) 838
therapy (828) 828
treatment outcome (812) 812
iodine radioisotopes - adverse effects (754) 754
iodine isotopes (753) 753
isotopes (746) 746
radiotherapy dosage (728) 728
thyroidectomy (686) 686
kinetics (685) 685
autoradiography (677) 677
thyroid cancer (659) 659
carcinoma (643) 643
pharmacology & pharmacy (584) 584
radiotherapy (583) 583
aged, 80 and over (582) 582
child (574) 574
nuclear medicine (563) 563
follow-up studies (562) 562
injections, intravenous (557) 557
thyroid neoplasms - pathology (539) 539
medicine & public health (536) 536
nuclei (528) 528
retrospective studies (525) 525
beta decay radioisotopes (524) 524
intermediate mass nuclei (522) 522
thyroid gland - metabolism (519) 519
odd-even nuclei (506) 506
care and treatment (499) 499
days living radioisotopes (493) 493
thyroid neoplasms - surgery (492) 492
combined modality therapy (486) 486
body (458) 458
tomography, emission-computed, single-photon (455) 455
thyroid neoplasms - diagnostic imaging (448) 448
neurosciences (445) 445
mice, nude (442) 442
surgery (441) 441
organs (440) 440
rats, inbred strains (439) 439
proteins (435) 435
rats, sprague-dawley (432) 432
brain - metabolism (431) 431
patients (417) 417
thyroid (416) 416
iodine 125 (405) 405
electron capture radioisotopes (402) 402
medicine (400) 400
radiopharmaceuticals (397) 397
diagnosis (393) 393
iodine radioisotopes - metabolism (392) 392
organic compounds (392) 392
radiation dosage (392) 392
hyperthyroidism (391) 391
radioimmunoassay (388) 388
radiopharmaceuticals - therapeutic use (385) 385
rabbits (380) 380
diseases (372) 372
liver - metabolism (372) 372
dose-response relationship, drug (367) 367
radioimmunotherapy (366) 366
i-131 (363) 363
radiology and nuclear medicine (351) 351
iodine 131 (349) 349
mammals (349) 349
brachytherapy (345) 345
pregnancy (343) 343
dosimetry (339) 339
tumors (336) 336
antibodies, monoclonal - therapeutic use (327) 327
expression (327) 327
mice, inbred balb c (326) 326
neoplasm transplantation (326) 326
radioiodine therapy (326) 326
radiopharmaceuticals - pharmacokinetics (325) 325
thyroid function tests (324) 324
thyroxine - blood (323) 323
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10800) 10800
German (170) 170
Japanese (150) 150
Russian (139) 139
French (115) 115
Chinese (57) 57
Spanish (56) 56
Italian (50) 50
Polish (37) 37
Portuguese (17) 17
Hungarian (12) 12
Danish (10) 10
Czech (8) 8
Dutch (4) 4
Swedish (3) 3
Bulgarian (2) 2
Croatian (2) 2
Hebrew (2) 2
Norwegian (2) 2
Romanian (2) 2
Serbian (2) 2
Slovak (2) 2
Turkish (2) 2
Ukrainian (2) 2
Korean (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10047, pp. 906 - 918
Summary Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the... 
Internal Medicine | ANTITHYROID DRUG-TREATMENT | SUBACUTE THYROIDITIS | MEDICINE, GENERAL & INTERNAL | RADIOIODINE THERAPY | SENSITIVE THYROTROPIN | PAINLESS THYROIDITIS | GRAVES-DISEASE | THYROTROPIN-RECEPTOR | CLINICAL ENDOCRINOLOGISTS GUIDELINES | CONSENSUS STATEMENT | AMERICAN THYROID ASSOCIATION | Graves Disease - diagnosis | Hyperthyroidism - diagnosis | Humans | Thyroid Crisis - therapy | Patient Care Team | Thyrotoxicosis - metabolism | Hyperthyroidism - metabolism | Thyrotoxicosis - drug therapy | Amiodarone - administration & dosage | Iodine Radioisotopes - adverse effects | Amiodarone - adverse effects | Iodine Radioisotopes - therapeutic use | Thyroid Hormones - blood | Female | Pregnancy Complications - metabolism | Hyperthyroidism - epidemiology | Adrenergic beta-Antagonists - therapeutic use | Graves Disease - metabolism | Antithyroid Agents - adverse effects | Diagnosis, Differential | Thyroid Hormones - biosynthesis | Drug Administration Schedule | Risk Factors | Antithyroid Agents - therapeutic use | Hyperthyroidism - therapy | Pregnancy Complications - diagnosis | Antithyroid Agents - administration & dosage | Graves Disease - therapy | Thyroidectomy - adverse effects | Thyrotoxicosis - diagnosis | Pregnancy | Iodine Radioisotopes - administration & dosage | Thyroid Crisis - diagnosis | Thyroid Gland - metabolism | Practice Guidelines as Topic | Pregnancy Complications - therapy | Medical colleges | Thyroid gland | Thyroid hormones | Radiotherapy | Adrenergic beta blockers | Hyperthyroidism | Hormones | Health risk assessment | Drug dosages | Iodine
Journal Article
Journal of Pharmaceutical Sciences, ISSN 0022-3549, 02/2015, Volume 104, Issue 2, pp. 705 - 713
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 18, pp. 1674 - 1685
In this trial, low-dose radioiodine was as effective as high-dose radioiodine in patients with differentiated thyroid tumors, and recombinant human thyrotropin... 
MEDICINE, GENERAL & INTERNAL | I-131 | THERAPY | SURVEILLANCE | PROGNOSTIC-SIGNIFICANCE | PAPILLARY | RADIOACTIVE IODINE | CARCINOMA | SERUM THYROGLOBULIN | IODINE REMNANT ABLATION | CONSENSUS REPORT | Ablation Techniques - psychology | Follow-Up Studies | Humans | Middle Aged | Male | Iodine Radioisotopes - adverse effects | Young Adult | Thyroid Hormones - blood | Aged, 80 and over | Adult | Female | Thyrotropin Alfa - therapeutic use | Ablation Techniques - adverse effects | Thyroid Hormones - therapeutic use | Thyrotropin Alfa - adverse effects | Length of Stay | Radiotherapy Dosage | Thyroid Neoplasms - surgery | Treatment Outcome | Combined Modality Therapy | Thyroid Neoplasms - radiotherapy | Thyroidectomy | Hypothyroidism - etiology | Iodine Radioisotopes - administration & dosage | Thyroid Neoplasms - drug therapy | Adolescent | Quality of Life | Aged | Drugs | Dose-response relationship (Biochemistry) | Usage | Care and treatment | Patient outcomes | Radiofrequency ablation | Product/Service Evaluations | Thyroid cancer | Thyrotropin | Dosage and administration | Drug therapy, Combination | Drug therapy | Isotopes | Iodine | Medical research | Data processing | Thyroid gland | Hypothyroidism | Patients | Lymph nodes | Quality of life | Metastases | Thyroid-stimulating hormone | Surgery | Triiodothyronine | Cancer | Thyroid
Journal Article
Thyroid : official journal of the American Thyroid Association, ISSN 1050-7256, 09/2017, Volume 27, Issue 9, pp. 1135 - 1141
Background: While there is a clear consensus for defining radioiodine-refractory differentiated thyroid cancer (RR-DTC), it is unknown whether these criteria... 
Phase 3 | radioiodine therapy | thyroid cancer | multitargeted kinase inhibitor | lenvatinib | MANAGEMENT | METASTASES | KINASE | PHASE-3 | ANTITUMOR ACTIVITIES | E7080 | THERAPY | ENDOCRINOLOGY & METABOLISM | INHIBITOR | Follow-Up Studies | Tumor Burden - radiation effects | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Iodine Radioisotopes - adverse effects | Tissue Distribution | Iodine Radioisotopes - therapeutic use | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Treatment Failure | Aged, 80 and over | Adult | Female | Radiopharmaceuticals - pharmacokinetics | Thyroid Neoplasms - mortality | Double-Blind Method | Phenylurea Compounds - therapeutic use | Terminology as Topic | Thyroid Neoplasms - radiotherapy | Iodine Radioisotopes - pharmacokinetics | Cross-Over Studies | Radiopharmaceuticals - administration & dosage | Iodine Radioisotopes - administration & dosage | Thyroid Neoplasms - drug therapy | Tumor Burden - drug effects | Protein Kinase Inhibitors - therapeutic use | Survival Analysis | Aged | Quinolines - therapeutic use | Radiopharmaceuticals - adverse effects | Dose-Response Relationship, Radiation | Quinolines - adverse effects | Radiopharmaceuticals - therapeutic use | Thyroid Neoplasms - pathology | Thyroid Cancer and Nodules
Journal Article
Thyroid, ISSN 1050-7256, 05/2013, Volume 23, Issue 5, pp. 69 - 616
Background: Chronic sialadenitis is one of the most frequent chronic complications after radioactive iodine (RAI) therapy for thyroid cancer. To evaluate the... 
Thyroid Radiology and Nuclear Medicine | QUANTITATIVE-EVALUATION | RADIOIODINE THERAPY | ENDOCRINOLOGY & METABOLISM | SJOGRENS-SYNDROME | FLOW-RATES | DYSFUNCTION | CARCINOMA | Sialadenitis - diagnostic imaging | Prevalence | Follow-Up Studies | Xerostomia - physiopathology | Submandibular Gland Diseases - epidemiology | Humans | Middle Aged | Submandibular Gland Diseases - diagnostic imaging | Submandibular Gland - secretion | Male | Iodine Radioisotopes - adverse effects | Salivary Glands - diagnostic imaging | Young Adult | Iodine Radioisotopes - therapeutic use | Submandibular Gland - diagnostic imaging | Salivary Glands - radiation effects | Adult | Female | Sialadenitis - etiology | Republic of Korea - epidemiology | Xerostomia - epidemiology | Sialadenitis - physiopathology | Severity of Illness Index | Thyroid Neoplasms - surgery | Sialadenitis - epidemiology | Salivary Glands - secretion | Thyroid Neoplasms - radiotherapy | Combined Modality Therapy - adverse effects | Thyroidectomy | Radiopharmaceuticals - administration & dosage | Submandibular Gland - radiation effects | Thyroid Neoplasms - physiopathology | Iodine Radioisotopes - administration & dosage | Radionuclide Imaging | Salivary Glands - physiopathology | Submandibular Gland - physiopathology | Submandibular Gland Diseases - physiopathology | Aged | Radiopharmaceuticals - adverse effects | Submandibular Gland Diseases - etiology | Xerostomia - etiology | Dose-Response Relationship, Radiation | Xerostomia - diagnostic imaging | Radiopharmaceuticals - therapeutic use
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 05/2015, Volume 100, Issue 5, pp. 1895 - 1902
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 04/2016, Volume 228, pp. 58 - 66
Journal Article